Correlation Between Janux Therapeutics and Alx Oncology
Can any of the company-specific risk be diversified away by investing in both Janux Therapeutics and Alx Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Janux Therapeutics and Alx Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Janux Therapeutics and Alx Oncology Holdings, you can compare the effects of market volatilities on Janux Therapeutics and Alx Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Janux Therapeutics with a short position of Alx Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Janux Therapeutics and Alx Oncology.
Diversification Opportunities for Janux Therapeutics and Alx Oncology
-0.57 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Janux and Alx is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Janux Therapeutics and Alx Oncology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alx Oncology Holdings and Janux Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Janux Therapeutics are associated (or correlated) with Alx Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alx Oncology Holdings has no effect on the direction of Janux Therapeutics i.e., Janux Therapeutics and Alx Oncology go up and down completely randomly.
Pair Corralation between Janux Therapeutics and Alx Oncology
Given the investment horizon of 90 days Janux Therapeutics is expected to under-perform the Alx Oncology. But the stock apears to be less risky and, when comparing its historical volatility, Janux Therapeutics is 1.45 times less risky than Alx Oncology. The stock trades about -0.16 of its potential returns per unit of risk. The Alx Oncology Holdings is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 146.00 in Alx Oncology Holdings on August 27, 2024 and sell it today you would earn a total of 1.00 from holding Alx Oncology Holdings or generate 0.68% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Janux Therapeutics vs. Alx Oncology Holdings
Performance |
| Timeline |
| Janux Therapeutics |
| Alx Oncology Holdings |
Janux Therapeutics and Alx Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Janux Therapeutics and Alx Oncology
The main advantage of trading using opposite Janux Therapeutics and Alx Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Janux Therapeutics position performs unexpectedly, Alx Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alx Oncology will offset losses from the drop in Alx Oncology's long position.| Janux Therapeutics vs. Mineralys Therapeutics, Common | Janux Therapeutics vs. Eliem Therapeutics | Janux Therapeutics vs. Anebulo Pharmaceuticals | Janux Therapeutics vs. Rezolute |
| Alx Oncology vs. Cabaletta Bio | Alx Oncology vs. Viracta Therapeutics | Alx Oncology vs. Eyepoint Pharmaceuticals | Alx Oncology vs. Biomea Fusion |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |